On May 31, 2022, Oncocross Co., Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,800 KRW | -10.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 7.06M | |
+47.81% | 1.04B | |
-24.60% | 884M | |
-12.28% | 420M | |
+41.13% | 401M | |
-19.58% | 380M | |
-1.67% | 327M | |
-9.95% | 262M | |
-45.37% | 241M | |
-46.99% | 236M |
- Stock Market
- Equities
- A299670 Stock
- News SM VINA Co., Ltd.
- Oncocross Co., Ltd. announced that it has received KRW 1.600015235 billion in funding from SM VINA Co., Ltd., C&M Trading Co., Ltd., DB Korea Discovery Co., Ltd.